4.8 Review

Honoring 50 Years of Clinical Heart Transplantation in Circulation In-Depth State-of-the-Art Review

Journal

CIRCULATION
Volume 137, Issue 1, Pages 71-87

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCULATIONAHA.117.029753

Keywords

heart transplantation; immunosuppression; survival

Funding

  1. Novartis
  2. CareDx
  3. TransMedics
  4. Abbott, Inc

Ask authors/readers for more resources

Heart transplantation has become a standard therapy option for advanced heart failure. The translation of heart transplantation from innovative experiments to long-term clinical success has married prescient insights with discipline and organization in the domains of surgical techniques, organ preservation, immunosuppression, organ donation and transplantation logistics, infection control, and long-term graft surveillance. This review explores the key milestones of the past 50 years of heart transplantation and discusses current challenges and promising innovations on the clinical horizon.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available